ASCO’s CancerLinQ® is the only nonprofit, physician-led health technology platform in oncology and focuses on empowering oncology practices and researchers to improve the quality of care and patient outcomes. CancerLinQ’s SmartLinQ™ platform supports the delivery of high-quality cancer care through practical tools including automated, near real-time, prospective quality measurement and interactive dashboards. SmartLinQ allows practices to eliminate manual chart abstraction for participation in the QOPI® Certification Program for maintenance and recertification. With CancerLinQ Discovery®, a real-world data product, researchers and clinicians can learn from the de-identified data to uncover new patterns in patient characteristics and outcomes to improve care.
Brands: https://events.jspargo.com/ASCO21/CUSTOM/cancerlinqbanner.jpg
Show Specials
Press Releases